[go: up one dir, main page]

YU51601A - Chimeric gene encoding the antigenic determinants of four proteins of l.infantum - Google Patents

Chimeric gene encoding the antigenic determinants of four proteins of l.infantum

Info

Publication number
YU51601A
YU51601A YU51601A YU51601A YU51601A YU 51601 A YU51601 A YU 51601A YU 51601 A YU51601 A YU 51601A YU 51601 A YU51601 A YU 51601A YU 51601 A YU51601 A YU 51601A
Authority
YU
Yugoslavia
Prior art keywords
proteins
gene encoding
chimeric gene
infantum
antigenic determinants
Prior art date
Application number
YU51601A
Other languages
Serbo-Croatian (sh)
Inventor
Alonso Carlos Bedate
Original Assignee
C.B.F. Leti S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.B.F. Leti S.A. filed Critical C.B.F. Leti S.A.
Publication of YU51601A publication Critical patent/YU51601A/en
Publication of RS50013B publication Critical patent/RS50013B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a pharmaceutical composition for the prevention and treatment, human or animal, of leishmaniasis. The pharmaceutical composition contains the protein chimera Q, which is the product of a chimeric gene encoding the antigenic determinants of four proteins of Leishmania infantum.
YUP-516/01A 1998-12-23 1999-12-23 Chimeric gene encoding the antigenic determinants of four proteins of l.infantum RS50013B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (en) 1998-12-23 1998-12-23 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans

Publications (2)

Publication Number Publication Date
YU51601A true YU51601A (en) 2005-07-19
RS50013B RS50013B (en) 2008-09-29

Family

ID=27671952

Country Status (5)

Country Link
JP (1) JP4883839B2 (en)
BR (1) BRPI9917863B8 (en)
CA (1) CA2256124C (en)
RS (1) RS50013B (en)
ZA (1) ZA200105994B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2638062B1 (en) * 2010-11-10 2018-04-25 Laboratorios LETI, S.L. New adjuvant

Also Published As

Publication number Publication date
JP2002533474A (en) 2002-10-08
ZA200105994B (en) 2002-07-22
BRPI9917863C1 (en) 2021-05-25
BRPI9917863B1 (en) 2016-08-02
BRPI9917863B8 (en) 2022-08-30
BRPI9917863A2 (en) 2010-12-21
JP4883839B2 (en) 2012-02-22
CA2256124C (en) 2015-06-16
CA2256124A1 (en) 2000-06-23
RS50013B (en) 2008-09-29

Similar Documents

Publication Publication Date Title
BE2016C049I2 (en)
DE69636760D1 (en) RECOMBINANT ANTI-CD4 ANTIBODY FOR HUMAN TREATMENT
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
PT2009025E (en) Method of inhibiting osteoclast activity
HK1043937A1 (en) Human therapeutic uses of bpi protein products
MXPA02010458A (en) Thrombopoietin receptor modulating peptide.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
ATE310828T1 (en) IMPLANT AND VECTOR FOR THE TREATMENT OF ACQUIRED DISEASES
MXPA04001986A (en) Compositions and methods for the treatment of immune related diseases.
WO2001095946A3 (en) Combination product for carrying out a cytotoxic treatment in a mammal
YU51601A (en) Chimeric gene encoding the antigenic determinants of four proteins of l.infantum
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
DE59410423D1 (en) SERIN-THREONINE-KINASE CONTAINING TUMOR THERAPY AND TUMOR DIAGNOSIS
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001016319A3 (en) Compositions and methods for the treatment of immune related diseases
ATE213637T1 (en) COMPOSITIONS CONTAINING BISMUTH FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
AU7043301A (en) A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence
ATE480560T1 (en) COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES
EP1624063A3 (en) Chimeric gene encoding the antigenic determinants of four proteins of L. infantum
MX9800686A (en) Novel protein hmw human mp52
EP1529842A3 (en) Compositions and methods for the treatment of immune related diseases